Why Do You Need Vision & Hearing Exams With Chelation?
At a Glance
Iron chelation medications like deferoxamine and deferasirox can cause vision and hearing side effects over time. Annual eye and hearing exams are crucial to catch these changes early so your doctor can adjust your medication dose, protecting your senses while safely managing your iron levels.
In this answer
3 sections
It can be confusing and overwhelming to juggle so many different specialist appointments for a blood disorder like beta-thalassemia major. You might wonder why an eye doctor or an audiologist is involved when the main issue is in the blood. The reason is not the disease itself, but the medication used to treat it: certain iron chelation drugs can cause changes to vision and hearing as side effects [1]. Regular exams help your care team catch these side effects early, often before you or your child even notice them [2].
Understanding Chelation Side Effects
Iron chelation therapy is life-saving and essential for removing excess iron caused by regular blood transfusions. However, the medications that do this important work—specifically deferoxamine and deferasirox—can sometimes affect the sensory organs, leading to ocular (eye) and auditory (ear) toxicity [1][3].
Eye Changes (Ocular Toxicity)
Over time, iron chelators can impact the retina, which is the light-sensitive layer at the back of the eye [4][5]. This can lead to a condition called retinopathy, where the retina is damaged, or sometimes the development of cataracts (clouding of the lens). Because these changes can start subtly, they are difficult to detect early without specialized equipment [5].
Hearing Changes (Auditory Toxicity)
Chelation medications can also affect the inner ear, potentially leading to sensorineural hearing loss [3]. This type of hearing loss usually starts at high frequencies. The risk of developing hearing loss with drugs like deferasirox is often linked to the dose and how long the medication has been taken [3].
Warning Signs to Watch For
While these side effects often develop slowly over time, you should not wait for your next scheduled annual exam if you notice symptoms [5]. Contact your hematology team immediately if you or your child experience:
- Night vision changes (struggling to see in low light)
- Decrease in visual sharpness (blurry vision or sitting closer to screens)
- Tinnitus (a persistent ringing or buzzing in the ears)
- Difficulty hearing in noisy environments or missing high-pitched sounds
Why Regular Exams Are Crucial
Standard care protocols require baseline and periodic screenings—usually every year—for anyone on long-term chelation therapy with deferoxamine or deferasirox [5].
- Comprehensive Eye Exams: An eye doctor will typically perform a slit-lamp exam to look at the front of the eye and use specialized imaging to check the health of the retina [4]. This process is painless, though it often involves eye drops to dilate the pupils, which can make the eyes temporarily sensitive to bright light.
- Audiograms (Hearing Tests): An audiologist will check how well sounds are heard across different frequencies to detect any early signs of high-frequency hearing loss [5]. This involves wearing headphones and responding to various beeps in a quiet room, which is also completely painless.
What Happens if a Problem is Found?
The goal of these exams is protection. If the eye doctor or audiologist detects early signs of toxicity, your hematologist can safely pause or adjust the dose of the chelation medication [2].
It is completely normal to worry that pausing the medication might cause dangerous iron buildup. However, your care team has safe backup plans. They may switch you or your child to a different chelator that does not carry the exact same sensory risks, or they may carefully manage a lower dose of your current medication. When caught early and managed properly, these side effects can often be stopped from progressing, and in many cases, sensory function can fully recover [2][6].
These appointments are a proactive way to ensure that the medication continues to protect your or your child’s organs from iron overload without harming vision or hearing.
Common questions in this guide
Why do I need to see an eye doctor and audiologist if I have a blood disorder?
What are the warning signs of eye or hearing damage from chelation therapy?
What happens if an eye or hearing test detects a problem from my iron chelator?
Are the vision and hearing changes caused by iron chelation permanent?
How often should I get vision and hearing exams while on iron chelation?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Vision and hearing checks
How often will I need eye and hearing exams while on chelation therapy?
Warning signs to know
What signs of eye or hearing changes should I report to my hematology team right away?
Medication adjustments
If an eye or hearing problem is found, could my hematologist pause or adjust my chelation medication?
Related questions
Show more
Get notified when new evidence is published on Beta-thalassemia major.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (6)
- 1
Hearing loss in Iranian thalassemia major patients treated with deferoxamine: A systematic review and meta-analysis.
Badfar G, Mansouri A, Shohani M, et al.
Caspian journal of internal medicine 2017; (8(4)):239-249 doi:10.22088/cjim.8.4.239.
PMID: 29201313 - 2
Deferoxamine-related bilateral maculopathy with optical coherence tomography findings.
Bayraktar Bilen N, Polat Gültekin B, Dagdas S, Kalayci D
Photodiagnosis and photodynamic therapy 2024; (45()):103961 doi:10.1016/j.pdpdt.2023.103961.
PMID: 38163453 - 3
Sensorineural Hearing Loss and Its Relationship with Duration of Chelation Among Major β-Thalassemia Patients.
Khan MA, Khan MA, Seedat AM, et al.
Cureus 2019; (11(8)):e5465 doi:10.7759/cureus.5465.
PMID: 31641562 - 4
Deferoxamine-induced electronegative ERG responses.
Jauregui R, Park KS, Bassuk AG, et al.
Documenta ophthalmologica. Advances in ophthalmology 2018; (137(1)):15-23 doi:10.1007/s10633-018-9640-3.
PMID: 29770904 - 5
Multimodal imaging in deferasirox-mediated retinopathy.
Caranfa J, Carrera W, Marmalidou A, et al.
European journal of ophthalmology 2024; (34(4)):NP33-NP37 doi:10.1177/11206721241245740.
PMID: 38562036 - 6
Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine.
Vahdani K, Makrygiannis G, Kaneshyogan H, et al.
European journal of ophthalmology 2016; (26(6)):e152-e154 doi:10.5301/ejo.5000840.
PMID: 27445073
This page provides educational information about sensory monitoring during iron chelation therapy. Always consult your hematologist, ophthalmologist, or audiologist for medical advice specific to your or your child's care.